Postpartum Depression (PPD) is one of the most common medical complications during and after pregnancy. Participants needed for new PPD research study at Insight.
During pregnancy, the levels of certain hormones rise and then rapidly fall after giving birth. Among other factors, these hormonal fluctuations have been associated with developing PPD symptoms. Symptoms of PPD may include extreme sadness, anxiety, or hopelessness and should not be ignored.
Symptoms may occur at any time during pregnancy or within the first few weeks after childbirth.
PPD can affect any woman, regardless of her age, race, ethnicity, or economic status. In the US, estimates of new mothers identified with PPD each year vary by state from 8% to 20%, with an overall average of 11.5%. Although awareness has improved, about 43% of women would not seek treatment because of a perceived stigma of PPD.
THE IMPACT OF POSTPARTUM DEPRESSION
Postpartum depression can have negative consequences on a mother and her family.
It can also impact the child’s health and development. If your PPD symptoms persist, it is important to reach out to your health care provider right away.
If you need immediate help, or you feel you may harm yourself or your baby, please dial 911 or your local emergency number. You can also call the National Suicide Prevention Lifeline, 800-273-8255, available 24 hours a day.
If you struggle with Post Partum Depression, consider participation in the Skylark research study.
Insight Clinical Trials is hosting a research study for severe postpartum depression
The SKYLARK STUDY is a research study evaluating an investigational oral medication in women with severe postpartum depression. To see if you may pre-qualify for the study, call Insight Clinical Trials at (216) 526-1843 or fill out this form.
You may qualify to participate if you are:*
18-45 years old
Gave birth within the last 12 months
Frequently feel extremely sad, anxious, or overwhelmed, and these symptoms are associated with severe PPD
Have symptoms that began no earlier than the third trimester and no later than the first 4 weeks following delivery
*The study doctor will discuss additional requirements.
During the screening visit, you will:
Meet with the study doctor and staff
Review additional information
Have an initial evaluation and undergo tests
Complete study questionnaires
If you qualify and decide to participate:
A study doctor will monitor your symptoms during the study
All study-related medication and medical care will be provided at no cost
Eligible participants may receive reasonable compensation for their time and travel.
Please talk to your doctor if you are interested in participating in this study.
To learn more about the SKYLARK STUDY and see if you may qualify, please call us at (216) 526-1843, email info@insightclinicaltrials.com or fill out this online contact form.
Click here to download a patient one-sheet. Free marketing materials are available by calling 216-526-1843.